Share

Johnson & Johnson begins Phase 3 COVID-19 vaccine candidate trial in SA

Johnson & Johnson’s Phase 3 trial of its COVID-19 vaccine candidate has commenced in South Africa. The first South African ENSEMBLE participants were dosed last week
Tue, 10 Nov 2020 17:55:49 GMT

Related Videos

Trending Tokens